Our previous data showed that A‐CpG ODN inhibits tumor growth in a mouse model via poly‐G motif‐mediated T cell activation.20 Our present data indicate the possibility of enhancement of antitumor immune responses to A‐CpG ODN via the IFN‐γ pathway in human lung cancer. Here, IFNG is linked to neoplasm.